169
Views
17
CrossRef citations to date
0
Altmetric
Review

Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis

Pages 1103-1116 | Published online: 22 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Bassem Yamout, Khalid El-Salem, Souheil Gebeily, Samia Khoury, Nuhad Abu Zeid, Khalid Hamoulila, Mohammed Salem Alhalabi, Zaki Noah Hasan, Hasan Al Hamadani, Hayder Hamoodi, Ammar Al Omar & Maurice Dahdaleh. (2014) Multiple sclerosis in the Levant: a regional consensus statement. International Journal of Neuroscience 124:5, pages 377-382.
Read now
Deborah Mukherji & Ruth Pettengell. (2010) Pixantrone for the treatment of aggressive non-Hodgkin lymphoma. Expert Opinion on Pharmacotherapy 11:11, pages 1915-1923.
Read now
Masaaki Niino & Hidenao Sasaki. (2010) Update on the treatment options for multiple sclerosis. Expert Review of Clinical Immunology 6:1, pages 77-88.
Read now

Articles from other publishers (14)

Saeed Bohlega, Jihad Inshasi, Abdel Rahman Tahan, Abu Bakr Madani, Hussien Qahtani & Peter Rieckmann. (2013) Multiple sclerosis in the Arabian Gulf countries: a consensus statement. Journal of Neurology 260:12, pages 2959-2963.
Crossref
Roberta Marolda, Chiara Ruocco, Chiara Cordiglieri, Chiara Toscani, Carlo Antozzi, Renato Mantegazza & Fulvio Baggi. (2013) Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis. Journal of Neuroimmunology 258:1-2, pages 41-50.
Crossref
Aaron J. Martin & Stephen D. Miller. 2013. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity 243 257 .
Aaron J. Martin, Derrick McCarthy, Carl Waltenbaugh, Gwen Goings, Xunrong Luo & Stephen D. Miller. (2010) Ethylenecarbodiimide-Treated Splenocytes Carrying Male CD4 Epitopes Confer Histocompatability Y Chromosome Antigen Transplant Protection by Inhibiting CD154 Upregulation. The Journal of Immunology 185:6, pages 3326-3336.
Crossref
S. Cotte, N. von Ahsen, N. Kruse, B. Huber, A. Winkelmann, U. K. Zettl, M. Starck, N. König, N. Tellez, J. Dörr, F. Paul, F. Zipp, F. Lühder, H. Koepsell, H. Pannek, X. Montalban, R. Gold & A. Chan. (2009) ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain 132:9, pages 2517-2530.
Crossref
Robbert G. van der Most, Andrew J. Currie, Sathish Mahendran, Amy Prosser, Anna Darabi, Bruce W. S. Robinson, Anna K. Nowak & Richard A. Lake. (2008) Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunology, Immunotherapy 58:8, pages 1219-1228.
Crossref
Robert Jay Schwartzman, Nicole Simpkins, Guillermo M. Alexander, Erin Reichenberger, Kristine Ward, Noah Lindenberg, David Topolsky & Pam Crilley. (2009) High-Dose Cyclophosphamide in the Treatment of Multiple Sclerosis. CNS Neuroscience & Therapeutics 15:2, pages 118-127.
Crossref
Loaie M El-Helw & Barry W Hancock. (2009) Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas. Future Oncology 5:4, pages 445-453.
Crossref
Sylvia E. Kim. (2012) Daclizumab Treatment for Multiple Sclerosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29:2, pages 227-235.
Crossref
Aaron J. Martin & Stephen D. Miller. 2009. Th 17 Cells: Role in Inflammation and Autoimmune Disease. Th 17 Cells: Role in Inflammation and Autoimmune Disease 185 199 .
E Cocco, C Sardu, P Gallo, R Capra, MP Amato, M Trojano, A Uccelli & MG Marrosu. (2008) Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Multiple Sclerosis Journal 14:9, pages 1225-1233.
Crossref
Federica Ubiali, Sara Nava, Valeria Nessi, Renato Longhi, Gabriella Pezzoni, Raffaella Capobianco, Renato Mantegazza, Carlo Antozzi & Fulvio Baggi. (2008) Pixantrone (BBR2778) Reduces the Severity of Experimental Autoimmune Myasthenia Gravis in Lewis Rats. The Journal of Immunology 180:4, pages 2696-2703.
Crossref
Wen-Hua Piao, Rudy Wong, Xue-Feng Bai, Jianhua Huang, Denise I. Campagnolo, Robert T. Dorr, Timothy L. Vollmer & Fu-Dong Shi. (2007) Therapeutic Effect of Anthracene-Based Anticancer Agent Ethonafide in an Animal Model of Multiple Sclerosis. The Journal of Immunology 179:11, pages 7415-7423.
Crossref
Karem Shanab, Nipawan Pongprom, Eva Wulz, Wolfgang Holzer, Helmut Spreitzer, Peter Schmidt, Babette Aicher, Gilbert Müller & Eckhard Günther. (2007) Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes. Bioorganic & Medicinal Chemistry Letters 17:22, pages 6091-6095.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.